New York State Common Retirement Fund Greenwich Life Sciences, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$7.14 - $20.36 $24,990 - $71,260	-3,500 Reduced 99.04%	34 $0
Q4 2021 Feb 02, 2022	SELL	$21.76 - $39.43 $174 - $315	-8 Reduced 0.23%	3,534 $86,000
Q3 2021 Nov 02, 2021	BUY	$38.65 - $46.11 $1,623 - $1,936	42 Added 1.2%	3,542 $138,000
Q2 2021 Aug 02, 2021	BUY	$31.24 - $53.6 $109,340 - $187,600	3,500 New	3,500 $157,000

645K

Ticker GLSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,848,200
Market Cap $222M
Description
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.